Table:
begin	end	state
1	20	cytoplasmic
21	43	transmembrane
44	51	non-cytoplasmic
52	74	transmembrane
75	102	cytoplasmic
103	125	transmembrane
126	130	non-cytoplasmic
131	149	transmembrane
150	160	cytoplasmic
161	182	transmembrane
183	200	non-cytoplasmic
201	224	transmembrane
225	244	cytoplasmic
245	266	transmembrane
267	286	non-cytoplasmic
287	312	transmembrane
313	347	cytoplasmic
348	365	transmembrane
366	370	non-cytoplasmic
371	394	transmembrane
395	414	cytoplasmic
415	435	transmembrane
436	446	non-cytoplasmic
447	467	transmembrane
468	489	cytoplasmic

Input:
>BWI76_RS19685
MVSDTKTTEAPGLRRELKARHLTMIAIGGSIGTGLFVASGATISQAGPGGALLSYILIGL
MVYFLMTSLGELAAFMPVSGSFATYGQNYVEEGFGFALGWNYWYNWAVTIAVDLVAAQLV
MTYWFPDAPGWVWSALFLGIMFLLNWISVKGFGEAEYWFSLIKVATVIIFIIVGVMMIFG
IFKGAQPAGWSNWVIDDAPFAGGFAAMIGVAMIVGFSFQGTELIGIAAGESENPEKNIPR
AVRQVFWRILLFYVFAILIISLIIPYTDPSLLRNDVKDISVSPFTLVFQHAGLLSAAAIM
NAVILTAVLSAGNSGMYASTRMLYTLACDGKAPRIFSKLSKGGVPRNALYATTVIAGLCF
LSSMFGNQTVYLWLLNTSGMTGFIAWLGIAISHYRFRRGYVLQGNDLNDLPYRSGFFPLG
PIFAFVLCLIITLGQNYEAFLKDTIDWGGVAATYIGIPLFLVIWFGYKLAKGTRFVRYSE
MKFPERFKG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server